Literature DB >> 11876757

Expression and functional activity of CXCR-4 and CCR-5 chemokine receptors in human thymocytes.

R Zamarchi1, P Allavena, A Borsetti, L Stievano, V Tosello, N Marcato, G Esposito, V Roni, C Paganin, G Bianchi, F Titti, P Verani, G Gerosa, A Amadori.   

Abstract

In this paper we addressed the expression of the HIV co-receptors CXCR-4 and CCR-5 in human thymocytes by phenotypic, molecular and functional approaches. Cytofluorimetric analysis disclosed that CXCR-4 was constitutively expressed by freshly isolated thymocytes (~10 000 molecules/cell in about 30% of thymocytes); the receptor was endowed with functional activity, as it mediated polarization, migration and intracellular Ca2+ increase in response to its ligand, SDF-1. On the contrary, CCR-5 expression in freshly isolated thymocytes was significantly lower (<4000 molecules/cell in less than 5% of the cells), and no functional response to CCR-5 agonists could be documented. Northern blot analysis of freshly isolated thymocytes showed high CXCR-4 mRNA levels, whereas the message for CCR-5 was barely detectable. On the other hand, a modest increase in the expression of CCR-5 was associated with in vitro thymocyte stimulation, and CCR-5 density at the cell surface attained CXCR-4 figures in most cases. None the less, no functional response to CCR-5 agonists could be documented in in vitro stimulated thymocytes. In vitro infection of thymocytes by CAT-expressing recombinant HIV bearing the envelope glycoproteins from different isolates showed that T-tropic strains, which use CXCR-4 as a co-receptor, were more efficient in infecting thymocytes than M-tropic strains, which preferentially use CCR-5. Altogether, these data indicate that expression of the major co-receptors involved in infection by M-tropic HIV strains is very poor in human thymocytes, and would suggest that thymocyte infection by M-tropic HIV strains may be a rare event in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876757      PMCID: PMC1906330          DOI: 10.1046/j.1365-2249.2002.01775.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

1.  Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic [correction of T cell-tropic] HIV-1 by three different monoclonal antibodies.

Authors:  T Hori; H Sakaida; A Sato; T Nakajima; H Shida; O Yoshie; T Uchiyama
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

2.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

3.  Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection.

Authors:  R Zamarchi; S Indraccolo; S Minuzzo; V Coppola; A Gringeri; E Santagostino; E Vicenzi; G De Silvestro; R Biagiotti; C Baldassarre; L Chieco-Bianchi; A Amadori
Journal:  AIDS Res Hum Retroviruses       Date:  1999-03-01       Impact factor: 2.205

4.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

5.  Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.

Authors:  J R Taylor; K C Kimbrell; R Scoggins; M Delaney; L Wu; D Camerini
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

Authors:  J Reynes; P Portales; M Segondy; V Baillat; P André; B Réant; O Avinens; G Couderc; M Benkirane; J Clot; J F Eliaou; P Corbeau
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

7.  CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes.

Authors:  J Arthos; A Rubbert; R L Rabin; C Cicala; E Machado; K Wildt; M Hanbach; T D Steenbeke; R Swofford; J M Farber; A S Fauci
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.

Authors:  M B Zaitseva; S Lee; R L Rabin; H L Tiffany; J M Farber; K W Peden; P M Murphy; H Golding
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

9.  CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation.

Authors:  R D Berkowitz; K P Beckerman; T J Schall; J M McCune
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

Authors:  L Wu; W A Paxton; N Kassam; N Ruffing; J B Rottman; N Sullivan; H Choe; J Sodroski; W Newman; R A Koup; C R Mackay
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  15 in total

1.  Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein.

Authors:  D Gibellini; M C Re; F Vitone; N Rizzo; C Maldini; M La Placa; G Zauli
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

2.  Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure.

Authors:  Pratip K Chattopadhyay; Daniel C Douek; Stephen J Gange; Karen R Chadwick; Marc Hellerstein; Joseph B Margolick
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

3.  Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Adrienne E Swanstrom; Gretja Schnell; Benhur Lee; James A Hoxie; Ronald Swanstrom
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

Review 4.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

Review 5.  Bioinformatic analysis of HIV-1 entry and pathogenesis.

Authors:  Benjamas Aiamkitsumrit; Will Dampier; Gregory Antell; Nina Rivera; Julio Martin-Garcia; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.

Authors:  Anding Shen; M Christine Zink; Joseph L Mankowski; Karen Chadwick; Joseph B Margolick; Lucy M Carruth; Ming Li; Janice E Clements; Robert F Siliciano
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  IFN-alpha-induced upregulation of CCR5 leads to expanded HIV tropism in vivo.

Authors:  Cheryl A Stoddart; Mary E Keir; Joseph M McCune
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

8.  T cell specific adapter protein (TSAd) interacts with Tec kinase ITK to promote CXCL12 induced migration of human and murine T cells.

Authors:  Tone Berge; Vibeke Sundvold-Gjerstad; Stine Granum; Thorny C B Andersen; Gunn B Holthe; Lena Claesson-Welsh; Amy H Andreotti; Marit Inngjerdingen; Anne Spurkland
Journal:  PLoS One       Date:  2010-03-18       Impact factor: 3.240

9.  NF-κB-inducing kinase contributes to normal development of cortical thymic epithelial cells: its possible role in shaping a proper T-cell repertoire.

Authors:  Koji Eshima; Kana Misawa; Chihiro Ohashi; Haruka Noma; Kazuya Iwabuchi
Journal:  Immunology       Date:  2020-04-13       Impact factor: 7.397

10.  Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes.

Authors:  Valeria de Mello Coelho; Allyson Bunbury; Leticia B Rangel; Banabihari Giri; Ashani Weeraratna; Patrice J Morin; Michel Bernier; Dennis D Taub
Journal:  Int J Med Sci       Date:  2009-12-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.